Skip to content
Search

Latest Stories

Clinical roles may be option for community pharmacists: Ed Waller

NHS ENGLAND’S Ed Waller has outlined plans for pharmacists to play a bigger clinical role in primary care, writes Priyankur Mandav.

Speaking at the fourth annual Pharmacy Business Conference in London last Thursday (26), Waller, who is NHS England’s director of primary care strategy and NHS contracts, said “thousands of pharmacists” would start working in general practices over the next five years.


“This is a pretty unique moment for community pharmacy,” Waller said. “Not only is there a five-year plan for the NHS, there is, alongside it, five-year contractual framework and plan for both community pharmacy and general practice.

“And what that means is the opportunity to plan in a way that hasn’t been possible before and to develop services and offers to patients that might take longer than a year cycle can deliver,” he added.

Waller noted that the NHS Long Term Plan was about integrating services around the patient more effectively, making inroads into the major “killer diseases” and causes of ill health.

He outlined three main ambitions – “making sure everyone gets the best start in life; delivering world-class care for major health problems, and supporting people to age well”.

Delegates at the conference were told about NHS goals to overcome specific challenges of personalised care, prevention and health inequalities as well as management of efficient workforce, data and digital technology – all geared toward delivering better value to the healthcare system.

Pharmacist asking question to the panel at the fourth Pharmacy Business Conference in London.

Waller said as the sector was preparing for the change, there would be opportunities for pharmacists to take on more clinical responsibilities.

“[It is] Worth being honest – some community pharmacists may take up clinical roles in the primary care network,” he said, hinting at portfolio careers for pharmacists. Stating that significant investment was made in primary care networks (PCNs) Waller said as part of multidisciplinary teams, community pharmacy had a big role to play in delivering urgent care services.

He told the conference that “an estimated up to six per cent of all GP consultations could be safely transferred to community pharmacists – which will be up to 20 million appointments a year”.

The conference also heard from Alastair Buxton, head of NHS services at the Pharmaceutical Services Negotiating Committee, who said during a panel discussion that this could be a “potential game-changer for community pharmacy”.

In addition, a number of award-winning pharmacists spoke about their individual success stories. During a discussion around ‘Developing a pharmacy business fit for the future’, James Tibbs and Shikha Rishi explained how introducing a range of new services added to their revenue stream. Rishi, who runs a medical aesthetics clinic in Bournemouth, spoke about how she found her niche in private services.

A superintendent pharmacist at Priory Community Pharmacy, Olutayo Arikawe, discussed self-care, saying it was something that pharmacists did every day. An advocate of Healthy Living Pharmacy (HLP) she told the conference that it was the best thing to have happened to community pharmacy. However, it was important that pharmacists continued to engage with their communities and supported the care of long-term conditions and patient choices, Arikawe said.

She asked her fellow pharmacists to identify gaps in their communities and strive towards filling them – these were money pots for community pharmacy, she revealed.

Michael Ball, pharmacist director at Broadway Pharmacy in Preston, explained how an all-out effort helped him push his vaccination efforts to reach a record number that earned him the second position in the UK last year. “It’s a significant revenue if done with real focus. Yes, it’s challenging, but helps showcase what you can do and generate income,” he said.

Speaking on the ‘Prevention is better than cure’ topic, Ade Williams said he looked at the government’s focus on ‘prevention’ as a pharmacy ‘call to arms’. But he believed “community pharmacy is the only place where the goals of the prevention agenda can be met”.

Ade also pointed out that with growing use of technology and focus on data in healthcare, it was important for pharmacists to “gather evidence in order to be able to show what you are doing."

More For You

Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less
Grant Thornton's Anuj Chande urges UK firms to tap booming India

Anuj Chande

Grant Thornton's Anuj Chande urges UK firms to tap booming India

INDIAN companies are well placed to support the UK’s economic growth, Eastern Eye has been told by Anuj Chande, partner and head of the South Asia Business Group at Grant Thornton.

He was speaking after the publication of Grant Thornton’s India Meets Britain Tracker 2025: The latest trends in Indian investment in the UK, which was released last week. While companies in India need little encouragement to enter the UK market, the reverse is not true.

Keep ReadingShow less